GlassScriptPhysician profile
Laura W Taylor
NPI 1114284759
$5,816.96
in general payments reported to CMS, 2019-2025
22 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,351 · 2022: $1,574 · 2023: $2,336 · 2024: $255 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.34 |
| Education | $221.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,339.82 | 2021-2025 | |
| Janssen Biotech, INC. | $729.70 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $575.98 | 2021-2023 | Winlevi, Absorica Ld, Ilumya |
| Regeneron Healthcare Solutions, INC. | $475.73 | 2021-2024 | Dupixent |
| Genzyme Corporation | $418.13 | 2021-2023 | |
| Pfizer INC. | $413.61 | 2021-2023 | |
| Lilly USA, LLC | $329.64 | 2021-2024 | Olumiant, Taltz |
| Leo Pharma INC. | $326.85 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $287.88 | 2021-2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.91 | 2021-2024 | Siliq, Jublia |
| Janssen Scientific Affairs, LLC | $136.34 | 2022 | |
| Globus Medical, INC. | $120.07 | 2023 | Proximal Humerus Strut |
| Almirall LLC | $102.34 | 2021-2023 | Seysara |
| Incyte Corporation | $93.45 | 2022-2024 | Opzelura |
| Ucb, INC. | $88.88 | 2021-2023 | Bimzelx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $61.46 | 2022-2023 | Sotyktu |
| Galderma Laboratories, L.P. | $43.66 | 2021-2023 | |
| Arcutis Biotherapeutics, INC. | $36.64 | 2025 | Zoryve |
| Dermavant Sciences, INC. | $33.52 | 2022-2023 | Vtama |
| Epi Health, LLC | $19.14 | 2021 | |
| Vyne Pharmaceuticals INC. | $19.05 | 2021 | |
| Merz North America, INC. | $16.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.